Ionis Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2007 | — | $59.6M | $138.6M |
| FY2008 | — | $147.4M | $224.0M |
| FY2009 | $11.5M | $291.7M | $105.3M |
| FY2010 | $148.8M | $244.5M | $70.1M |
| FY2011 | $145.6M | $171.4M | $65.5M |
| FY2012 | — | $182.8M | $124.5M |
| FY2013 | — | $378.4M | $160.0M |
| FY2014 | — | $257.8M | $143.0M |
| FY2015 | — | $200.8M | $128.8M |
| FY2016 | — | $99.6M | $84.7M |
| FY2017 | — | $281.0M | $129.6M |
| FY2018 | — | $1.05B | $278.8M |
| FY2019 | $785.5M | $1.47B | $683.3M |
| FY2020 | $539.1M | $743.3M | $397.7M |
| FY2021 | — | $771.7M | $869.2M |
| FY2022 | $1.18B | $572.9M | $276.5M |
| FY2023 | $1.24B | $386.7M | $399.3M |
| FY2024 | $1.20B | $588.4M | $242.1M |
| FY2025 | $1.33B | $489.1M | $372.3M |